Pseudorabies virus (PRV) early protein 0 (EP0) contains the RING finger domain with homology to the immediate-early (IE) protein ICP0 of herpes simplex virus type 1 (HSV-1). EP0 was detected by indirect immunofluorescence in the nuclei of the cells transfected with EP0 expression plasmid as is the case in cells infected with PRV. In transient expression assays, EP0 transactivated the PRV IE, thymidine kinase (TK) and glycoprotein X (gX) promoters, indicating that EP0, like ICP0 of HSV-1, is a transactivating protein.
Pseudorabies virus (PRV) is a member of the genus
Varicellovirus of the subfamily Alphaherpesvirinae (Francki et al., 1991) . EP0 has been reported by Cheung (1991) to be a homologue of ICP0 of herpes simplex virus type 1 (HSV-1), which plays an important role in the transcriptional regulation of the HSV-1 genes. The EP0 gene is located at the end of the unique long region ( Fig.  1 ) and transcribed in the same direction as the immediateearly (IE) gene but in the opposite direction with respect to the latency gene, which is transcribed during latency (Cheung, 1991) . EP0 mRNA seems to be a spliced transcript of approximately 1"75 kb and has an ORF of 1230 nucleotides encoding a polypeptide of 410 amino acid residues with a molecular weight of 45 kDa (Cheung, 1991) .
Near its amimo terminus EP0 contains a RING finger domain with homology to ICP0 and its homologues, ORF61 of varicella-zoster virus (VZV) (Moriuchi et al., 1992) , p135 (BICP0) of bovine herpesvirus 1 (BHV-1) (Fraefel et al., 1994; Wirth et al., 1992) and the gene 63 product of equine herpes virus 1 (EHV-1) (Everett et al., 1993a) . The RING finger domain is thought to be important for the function of ICP0 homologues. Among the ICP0 homologues, HSV-1 ICP0 and VZV ORF61 are IE gene products, whereas PRV EP0 and BHV-1 p135 (BICP0) are early gene products. ICP0 of HSV-1 is a promiscuous transactivator (O'Hare & Hayward, 1985) , ORF61 of VZV seems to act as a transactivator (Moriuchi et al., 1993; Nagpal & Ostrove, 1991) and p135 (BICP0) of BHV-1 acts as both a transactivator and a repressor (Wirth et al., 1992) . These findings suggest that EP0 may have transcriptional regulatory activities.
In the present study, we constructed an expression plasmid encoding EP0 in order to characterize the function of EP0 in the cells infected with PRV. The transcription regulatory activities of EP0 were examined by transfection assays.
PRV strain YS-81 was kindly provided by M. Shimizu (National Institute of Animal Health, Tsukuba, Japan). An EP0 expression plasmid was constructed as follows ( Fig. 1 ): PRV genomic DNA was digested with KpnI and the KpnI-F fragment containing the EP0 gene was cloned into the KpnI site of plasmid pGEM-4Z (Promega). The plasmid was designated pG/KpnI-F [ Fig. 1 b(i) ], Two BamHI fragments in pG/KpnI-F were deleted by BamHI digestion of this plasmid, and then one (containing about 97 % of the EP0 gene ORF) of the BamHI fragments was inserted into the BamHI site of the plasmid [ Fig. 1 b(i) ]. By this procedure, an approximately 1'7 kb BamHI fragment upstream from the EP0 gene was deleted from pG/KpnI-F [ Fig. l b(i) ]. This plasmid was designated pG/F-EP0. Plasmid pG/F-EP0 was digested with HindIII and NotI. This HindIII-NotI fragment containing the EP0 gene was transferred into the HindllI and NotI sites of eukaryotic expression vector pcDNAI/ Amp (Invitrogen). This plasmid was designated pcEP0 (Fig. 1 c) . The nucleotide sequence of the cloned EP0 gene was determined by the dideoxynucleotide chain termination method described by Sanger et al. (1977) using a Sequenase version 2.0 kit (United States Biochemical) and compared with that of the PRV Indiana-Funkhauser (InFh) EP0 gene reported by Cheung (1991) . Only one nucleotide change was found between the two strains (T in YS-81 versus C in InFh at nucleotide position 537 from A of the translation initiation codon). This nucleotide change, however, did not lead an amino acid change.
In vitro transcription and translation of pcEP0 was performed as described by Patwardhan & Gupta (1988) . Plasmid pcEP0 contains the human cytomegalovirus IE promoter (CMV P) and SV40 polyadenylatxon signal (PA). The restriction sites in the plasmids used for the construction are indicated.
The synthesized protein was analysed by 10% SDS-PAGE (Fig. 2a) . A protein band with an apparent molecular mass of approximately 68 kDa was found, although the mobility of this band was lower than that of the predicted molecular mass (45 kDa). This discrepancy of the molecular mass values of EP0 between the observed and predicted on the basis of the amino acid sequence may be due to the fact that EP0 contains the RING finger motif as was reported for HSV-1 ICP0 by Everett et al. (1993b) . To construct a plasmid expressing a Protein A-EP0 fusion protein, the Eco47III-BamHI fragment of pcEP0 was cloned into the SmaI and BamHI sites of a fusion vector pRIT2T encoding the Protein A gene (Pharmacia). The Protein A-EP0 fusion protein was purified from the cytoplasm of Escherichia coli N4830-1 which had been transformed with the plasmid as described by Nilsson et al. (1985) . Polyclonal antiserum to EP0 was obtained from a rabbit immunized with the purified Protein A-EP0 fusion protein.
To test the reactivity of anti-EP0 serum, COS-1 cells infected with PRV were examined by indirect immunofluorescence. The nuclei of PRV-infected cells were obviously stained at 6 h post-infection, but no signal was observed in mock-infected cells (Fig. 2 b) . To examine the expression and the localization of EP0 in the absence of other viral proteins, COS-1 ceils, kindly provided by K.C. Gupta (Rush University, Chicago, USA), were transfected with pcEP0 and analysed by indirect immunofluorescence. Transfection was performed by using Lipofectin reagent (Gibco BRL) as directed by the manufacturer. Accumulation of EP0 was found in the nuclei as observed in PRV-infected cells (Fig. 2b) .
COS-1 cells grown in 60 mm dishes were transfected with 6 gg ofpcEP0 or infected with PRV at 10 p.f.u./cell. At 48 h post-transfection or 5 h post-infection (p.i.), the cells were harvested and lysed in RIPA buffer (20 mMTris-Cl pH 7'5, 2 mM-EDTA, 0.15 M-NaC1, 1% sodium deoxycholate, 1% Triton X-100 and 0.1% SDS) containing 1 mM-PMSF, 1 ~tg/ml leupeptin and 1 ~g/ml aprotinin, The lysates were sonicated and precipitated with cold acetone, The precipitated samples were analysed by Western immunoblotting. In PRV-infected or pcEP0-transfected cells, EP0 was detected as two major bands (approximately 68 kDa and 76 kDa) (Fig.  2 c, lanes 2 and 3) . No band was detected when preimmune serum was used (data not shown). In pcEP0-transfected cells, 68 kDa and 76 kDa proteins were present in approximately equal amounts, whereas in the PRVinfected cells, 68 kDa protein was dominant. In PRVinfected cells, only 68 kDa protein was detected at 2 h p.i. and 76kDa protein was detected at 4 h p.i. in addition to 68 kDa protein. Furthermore, the amount of 76 kDa protein gradually increased at 6 h p.i. (data not shown). These results indicate that the 76 kDa protein may be due to some post-translational modification such as phosphorylation and could explain the different proportions of the two proteins in the transfected and infected cells.
To examine the effect of EP0 on transcription regulation, the chloramphenichol acetyltransferase (CAT) assay was performed as described previously (Taharaguchi et al., 1994) . Plasmid pcEP0 was cotransfected with the PRV IE, early or early-late promoter-- CAT construct (pRWTCAT, ptks/CAT or pgX/CAT) into Vero cells. Plasmid pRW7CAT containing the CAT gene flanked by the PRV IE promoter (Vl~ek et al., 1990) was kindly provided by M. Schwyzer (University of Zurich, Zurich, Switzerland). Plasmid ptks/CAT and pgX/CAT contain the CAT gene flanked by the PRV TK and gX promoter, respectively (Taharaguchi et at., 1994) . In addition to pcEP0, pcIE (Taharaguchi et al., 1994) expressing PRV IE180 and pRG4 (Greaves & O'Hare, 1989) expressing HSV-1 Vmw65 were used as the control of the effector plasmid. Plasmid pRG4 was a generous gift of Peter O'Hare (Marie Curie Research Institute, Surrey, UK). These gene products are expressed under the control of human cytomegalovirus IE promoter. As shown in Fig. 3 , EP0 transactivates CAT expression under the control of PRV TK, gX and IE promoters (Fig. 3a, b and c) , and the maximum expression was 5-1-fold, 13.8-fold and 9.6-fold, respectively, as compared with the control. In the control experiments, IE180 repressed transcription from the PRV IE promoter (Fig. 3j) and stimulated transcription from the PRV TK and gX promoters (Fig. 3d, e) . Although Vmw65 strongly enhanced transcription from the PRV IE promoter (Fig. 30 , significant trans-activation was not observed when ptks/CAT and pgX/CAT were used as the reporter plasmid (Fig. 3g, h ). EP0 enhanced IE, early and early-late gene transcription of PRV in transient expression assays, indicating that EP0 acts as a transactivator in the virus-infected cells like ICP0 of HSV-1 and the homologous proteins of other alphaherpesviruses (O'Hare & Hayward, 1985; Moriuchi et al., 1993; Wirth et al., 1992) . The mechanism of transactivation for the expression of the PRV gene by EP0 is unclear. The RING finger and strongly acidic regions of EP0 may serve as a binding domain and a transcriptional activation domain, respectively.
The RING finger domain is thought to be important for DNA-binding, RNA-binding, or protein-protein interactions (Freemont, 1993) . However, the RING finger domains of HSV-1 ICP0, VZV ORF61 and EHV-1 gene 63 product bind zinc ions, but not DNA or RNA (Everett et al., 1993a) . The RING finger domains of HSV-1 ICP0 and VZV ORF61 are thought to have roles critical for transactivation (Everett, 1988; Moriuchi et al., 1994) . Therefore, these ICP0 homologues may stimulate transcription from the viral gene promoters by interaction with cellular transcription factors. Thus, the RING finger domain of EP0 may also play similar roles in the biology of PRV.
It is known that acidic regions are critical determinants of activation potential in acidic transactivators (Mitchell & Titan, 1989) . EP0 molecule contains two acidic regions (amino acids 111 to 118 and 130 to 142) and a similar acidic region was retained in each molecule of HSV-1 ICP0 (amino acids 1 to 115 and 233 to 243), VZV ORF61 (amino acids 71 to 105) and BHV-1 p135 (BICPO) (amino acids 280 to 330). There is, however, no apparent amino acid identity among these ICP0 hornologues in these acidic regions. Therefore, the significance of these acidic regions in these proteins is unknown. Further studies on structure/function relationship in EP0 are required. At present, various EP0 mutants are constructed and mapping of functional domains of EP0 is in progress.
